Pacemakers were implanted in 10 of 14 patients with dizziness and syncopal episodes of long duration, due to sino-atrial block. Paroxysmal supraventricular tachycardia, notably atrial fibrillation, had occurred in 6 patients. Medical treatment was unsatisfactory in 3 of these and pacemaker therapy was given. This abolished both syncope and paroxysmal tachycardia. Sinoatrial block and supraventricular tachycardia are probably not only different expressions of the same pathological process; a functional relation seems likely.
Sino-atrial block may, on rare occasions, cause syncopal episodes which can be prevented by pacemaker therapy. Another complication is paroxysmal, rapid, supraventricular rhythms, notably atrial fibrillation. Treatment is then difficult. Cardio-accelerator drugs, such as atropine or isoprenaline, may precipitate tachycardia, while antiarrhythmic agents, such as quinidine, digitalis, or propranolol, can accentuate bradycardia and cause syncope. A logical approach seems to be the combination of pacemaker to prevent bradycardia, and antiarrhythmic drugs in sufficient doses to prevent tachycardia. Successful use of the pacemaker was reported by Cohen, Kahn, and Donoso (I967) in a patient with chronic sinus and nodal bradycardia and paroxysmal atrial flutter.
The purpose of this paper is to show that sino-atrial block can quite often be associated with paroxysmal atrial fibrillation, and that pacemaker therapy may prevent both syncope and fibrillation.
Patients and methods
During the past 4 years sino-atrial block was the main diagnosis in I4 patients admitted to the Section of Cardiology, Medical Department, Central Hospital, Trondheim. Neither patients with recent myocardial infarction nor those whose symptomless sino-atrial block was discovered accidentally, were included. A summary of clinical data is shown in the of moderate angina pectoris. Otherwise, none showed any underlying cause fcr the block such as hypertension, valvular, coranary, thyrotoxic, syphilitic, or pulmonary heart disease. It is noted, however, that 3 patients gave a history of rheumatic fever, and 2 of diphtheria.
Before symptoms appeared none of the patients had taken drugs, such as digitalis or quinidine, which might cause arrhythmia. Hyperkalaemia was not seen. The age at which symptoms began varied from 43 to 7I years and the duration of symptoms from 6 months to I7 years. Twelve patients had repeated attacks of dizziness and/or syncope. Six of these had, in addition, episodes of rapid, irregular heart beats lasting a few minutes to a few hours. A relation between syncope and tachycardia could only be established in one (Case I3) . A few patients complained of moderate dyspnoea on exertion and one (Case II) had ankle oedema. Otherwise, no signs of congestive heart failure were found, but cardiomegaly was sometimes shown on x-ray, all four chambers being equally enlarged.
Frequent electrocardiograms were made in all patients. Monitoring devices have been available since early I967. In the Table, 'S-A block' indicates the appearance of a normal PQRS after a pause of about twice the normal length. 'Sinus arrest' arbitrarily indicates a somewhat longer pause, up to several seconds, with a nodal escape beat at the end. All patients had bradycardia, the basic heart rate being less than 6o a minute. Electrocardiograms taken in the 6 patients with paroxysmal tachycardia showed ventricular rates varying from I40 to i8o during paroxysms. One patient had possible nodal tachycardia, another had frequent supraventricular extrasystoles, and 4 had atrial fibrillation. ienced a tendency to syncope sometimes at the beginning, sometimes shortly after tachycardia, but most often syncope was unconnected with tachycardia. Quinidine sulphate, 0-2 g. 4 times, increased the tendency to syncope. Digitoxin, 0oi mg. a day, combined with procainamide hydrochloride, 250 mg. 4 times, reduced the attacks of tachycardia, but bradycardia was accentuated and he became dyspnoeic on exertion.
He was admitted to the Section of Cardiology in August i967. Fig. 2 shows some examples of his arrhythmia. Clinical and laboratory findings were otherwise normal except cardiomegaly on chest x-ray. A transvenous electrode was placed in the right ventricle and connected with an external 'fixed-rate' pacemaker but had to be removed after one hour because of repeated paroxysms of supraventricular tachycardia. He was readmitted in April I968, and an 'on-demand' pacemaker was connected. The medication was digitoxin and procainamide as above. When the pacemaker was connected, supraventricular tachycardia with a rate of i6o a minute reappeared. After lanatoside C, o04 mg., and procainamide hydrochloride, 6oo mg., intravenously, a 'normal' pacemaker rhythm, 72 per minute, took over. After operation, he received procainamide hydrochloride, 500 mg. four times, and digitoxin, O-I mg. daily. The former drug was later gradually discontinued. His condition improved considerably, dyspnoea was reduced, and he had no dizziness, syncope, or tachycardia for I2 months after the second pacemaker was implanted.
Case 14 A man of 76 was admitted to the Section of Cardiology in August I968. He had been healthy until seven years previously when syncope occurred with increasing frequency, up to 4 times a day. A year after his first syncope he had attacks of rapid, irregular heart beats which became gradually more frequent, up to several times a week, and lasted for many hours. There was no relation between tachycardia and syncope. Treatment with ephedrine hydrochloride, ephedrine plus digitalis, atropine, or quinidine, was without effect. Digitalization alone had no effect Pacemaker therapy in sino-atrial block complicated by paroxysmal tachycardia 97 on tachycardia, and syncope occurred more often even after low doses (o o5 mg. digitoxin a day). The electrocardiogram showed sinus bradycardia, sinus arrest, and paroxysmal atrial fibrillation (Fig. 3) . Otherwise, clinical and laboratory findings were normal. A 'fixed-rate' pacemaker was implanted, and for the 8 months following implantation he has had no syncope or tachycardia. All drugs have been discontinued. Technique of pacemaker therapy In one patient (Case 5) epicardial electrodes were applied during thoracotomy and connected to an implanted Medtronics pulse generator, Model 5870 C. In the other 9 a catheter electrode was introduced through the external jugular vein to the apex of the right ventricle under fluoroscopic and electrocardiographic control. The pacemaker was implanted subcutaneously below the clavicle. The procedure took place under local anaesthesia in the cardiac catheterization laboratory. Unipolar Cordis electrodes were used in 8 patients and a bipolar Medtronics in one. The pacemakers were 'fixed-rate' Cordis Ventricor, Model I, C, in 7 patients, Cordis Ectocor 'on-demand', Model III, I29 E, in i, and Medtronics Model 5870 C in the ninth.
A broad spectrum antibiotic was administered, usually for 3 or 4 days. No anticoagulants were given. Complications In 3 patients there was superficial post-operative wound infection which subsided after prolonged antibiotic therapy. The only serious complication occurred in Case 6; this patient was twice treated for staphylococcal septicaemia, 6 months and i year after pacemaker implantation. During the first episode she had an attack of rapid atrial fibrillation which subsided after lanatoside C intravenously. She had a superficial wound infection in the neck which ultimately healed, and for the past i8 months she has had no trouble. Comments Sino-atrial block or sinus arrest as an expression of 'sick sinus node' (Lown, I966) was considered to be the basic rhythm disturbance in our patients. It is often impossible to differentiate between the two mechanisms, and they may coexist in the same patient. As regards the underlying cause it is noted that 5 patients had a history of rheumatic fever or diphtheria. Another 2 were mother and son ( It is interesting to note that nearly half of the patients had paroxysmal tachycardia, notably atrial fibrillation. Stock (I969) noted that two of his patients with sino-atrial block developed chronic atrial fibrillation and then lost their dizziness and syncopal attacks. Such a course was not noted in any of our patients, despite a clinical history of up to I7 years. In myocardial infarction with occlusion of the sinus node artery, atrial fibrillation or sino-atrial block sometimes with slow nodal escape rhythm have been reported by many authors (James, I96I; Cancilla and Nicklaus, I966; Lippestad and Marton, I967). It appears from our study that paroxysmal, rapid, atrial rhythms are fairly frequent in patients with sino-atrial block and syncope over years, a fact that is little emphasized in textbooks on cardiology, though Levine as early as I9I6, in a survey of i8 patients collected from published papers or studied personally, noted paroxysmal atrial fibrillation in 4 of them. Since then scattered case reports have appeared presenting sino-atrial block associated with paroxysms of atrial flutter (Jervell, I945) or atrial tachycardia (Laake, 1946) . Such patients present a difficult problem, as drugs, alone or in combination, are often unsuccessful or cause a deterioration of symptoms. The use of quinidine seemed to us especially harmful, and was associated with more frequent syncopal attacks despite the rather small doses of no more than 0-2 g. four times a day. Digitalis was occasionally used with some success, but was also sometimes associated with more frequent syncopal attacks. Isoprenaline was useful in one patient, but probably provoked paroxysmal atrial fibrillation in two others. The difficulties of medical treatment in sinoatrial block have also been mentioned by Greenwood and Finkelstein (I964) .
As 3 of the 6 patients with the combination of bradycardia and tachycardia were severely incapacitated, pacemaker therapy seemed to be the last resort. Today an 'on-demand' pacemaker, functioning only during bradycardia, seems to be the best approach instead of one with 'fixed rate' where interference phenomena in the case of paroxysmal tachycardia might give rise to problems. The former type was used only in one patient. In the other two a 'fixed-rate' pacemaker was applied, either because of limited experience with the 'on-demand' pacemaker, or because it was not available at the particular time. However, the therapy was successful also in these two patients. In one of them the pacemaker has completely taken over, and the other is unaware of the occasional interference with his own rhythm.
In patients with total atrioventricular block and Adams-Stokes syndrome due to paroxysmal ventricular tachycardia or fibrillation, the attacks of tachyarrhythmia have been abolished by increasing the basic heart rate either with drugs such as isoprenaline or ephinephrine (Linenthal and Zoll, i963) or by pacemaker (Zoll, Linenthal, and Zarsky, I960) . It is interesting to note that a similar principle probably applies to paroxysmal supraventricular tachycardialfibrillation occurring in sinus bradycardia with sino-atrial block. In one of our patients syncope and tachycardia have been controlled by pacemaker plus digitalis, while identical doses of digitalis prior to pacemaker implantation were unable to prevent paroxysmal tachycardia. In two others pacemaker therapy alone has abolished not only syncopal attacks, but also paroxysmal atrial fibrillation, as they had no such attacks after pacemaker implantation despite discontinuing antiarrhythmic drugs.
A fumctional relation between sino-atrial block and atrial fibrillation in these two patients seems probable.
